These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 19176691)
1. A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model. Bentancor LV; Bilen M; Brando RJ; Ramos MV; Ferreira LC; Ghiringhelli PD; Palermo MS Clin Vaccine Immunol; 2009 May; 16(5):712-8. PubMed ID: 19176691 [TBL] [Abstract][Full Text] [Related]
3. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. Gu J; Liu Y; Yu S; Wang H; Wang Q; Yi Y; Zhu F; Yu XJ; Zou Q; Mao X Microbes Infect; 2009 Sep; 11(10-11):835-41. PubMed ID: 19427397 [TBL] [Abstract][Full Text] [Related]
4. A recombinant hybrid peptide composed of AAF adhesin of enteroaggregative Escherichia coli and Shiga toxin B subunit elicits protective immune response in mice. Oloomi M; Bouzari S; Emami S Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1311-6. PubMed ID: 19655181 [TBL] [Abstract][Full Text] [Related]
5. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2. Bentancor LV; Mejías MP; Pinto A; Bilen MF; Meiss R; Rodriguez-Galán MC; Baez N; Pedrotti LP; Goldstein J; Ghiringhelli PD; Palermo MS mBio; 2013 Oct; 4(5):e00501-13. PubMed ID: 24085779 [TBL] [Abstract][Full Text] [Related]
6. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B. Zhu C; Yu J; Yang Z; Davis K; Rios H; Wang B; Glenn G; Boedeker EC Clin Vaccine Immunol; 2008 Feb; 15(2):359-66. PubMed ID: 18003816 [TBL] [Abstract][Full Text] [Related]
7. Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice. Mejias MP; Ghersi G; Craig PO; Panek CA; Bentancor LV; Baschkier A; Goldbaum FA; Zylberman V; Palermo MS J Immunol; 2013 Sep; 191(5):2403-11. PubMed ID: 23918978 [TBL] [Abstract][Full Text] [Related]
8. Isolation of B subunit-specific monoclonal antibody clones that strongly neutralize the toxicity of Shiga toxin 2. Arimitsu H; Sasaki K; Iba Y; Kurosawa Y; Shimizu T; Tsuji T Microbiol Immunol; 2015 Feb; 59(2):71-81. PubMed ID: 25521016 [TBL] [Abstract][Full Text] [Related]
9. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera. Mejias MP; Cabrera G; Fernández-Brando RJ; Baschkier A; Ghersi G; Abrey-Recalde MJ; Miliwebsky E; Meiss R; Goldbaum F; Zylberman V; Rivas M; Palermo MS Infect Immun; 2014 Apr; 82(4):1491-9. PubMed ID: 24421050 [TBL] [Abstract][Full Text] [Related]
13. Large-scale preparation of Shiga toxin 2 in Escherichia coli for toxoid vaccine antigen production. Arimitsu H; Sasaki K; Shimizu T; Tsukamoto K; Shimizu T; Tsuji T Microbiol Immunol; 2013 Jan; 57(1):38-45. PubMed ID: 23157558 [TBL] [Abstract][Full Text] [Related]
14. Development of DNA vaccines against hemolytic-uremic syndrome in a murine model. Capozzo AV; Pistone Creydt V; Dran G; Fernández G; Gómez S; Bentancor LV; Rubel C; Ibarra C; Isturiz M; Palermo MS Infect Immun; 2003 Jul; 71(7):3971-8. PubMed ID: 12819084 [TBL] [Abstract][Full Text] [Related]
15. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2. Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486 [TBL] [Abstract][Full Text] [Related]
17. Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice. Gao X; Cai K; Li T; Wang Q; Hou X; Tian R; Liu H; Tu W; Xiao L; Fang L; Luo S; Liu Y; Wang H Vaccine; 2011 Sep; 29(38):6656-63. PubMed ID: 21742003 [TBL] [Abstract][Full Text] [Related]
18. Functional capacity of Shiga-toxin promoter sequences in eukaryotic cells. Bentancor LV; Bilen MF; Mejías MP; Fernández-Brando RJ; Panek CA; Ramos MV; Fernández GC; Isturiz M; Ghiringhelli PD; Palermo MS PLoS One; 2013; 8(2):e57128. PubMed ID: 23451160 [TBL] [Abstract][Full Text] [Related]
19. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice. Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051 [TBL] [Abstract][Full Text] [Related]